Abstract:Background Cervical cancer, one of the leading causes of female deaths, remains a top cause of mortality in gynecologic oncology and tends to affect younger individuals. However, the pathogenesis of cervical cancer is still far from clear. Given the high incidence and mortality of cervical cancer, uncovering the causes and pathogenesis as well as identifying novel biomarkers are of great significance and are desperately needed. Materials and methods First, raw data were downloaded from the Gene Expression Omnibus database. The Robuse Multi-Array Average algorithm and combat function of the sva package were subsequently applied to preprocess and remove batch effects. Differentially expressed genes (DEGs) analyzed with the limma package were followed by gene ontology and pathway analysis, and a protein–protein interaction (PPI) network based on the STRING website and the Cytoscape software was constructed. Weighted Correlation Network Analysis (WGCNA) was utilized to build the coexpression network. Subsequently, UALCAN websites were employed to conduct survival analysis. Finally, the oncomine database was used to validate the expression of ANLN in other datasets. Results GSE29570 and GSE89657, including 49 cervical cancer tissues and 20 normal cervical tissues, were screened as the datasets. Three-hundred-twenty-four DEGs were identified and, among them, 123 were upregulated, while 201 were downregulated. The DEGs PPI network complex, contained 305 nodes and 4,962 edges, and 8 clusters were calculated according to k-core =2. Among them, cluster 1, which had 65 nodes and 1,780 edges, had the highest score in these clusters. In coexpression analysis, there were 86 hubgenes from the Brown modules that were chosen for further analysis. Sixty-one key genes were identified as the intersecting genes of the Brown module of WGCNA and DEGs. In survival analysis, only ANLN was a prognostic factor, and the survival was significantly better in the low-expression ANLN group. Conclusion Our study suggested that ANLN may be a potential tumor oncogene and could serve as a biomarker for predicting the prognosis of cervical cancer patients.

Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients

Overexpression of Anillin (ANLN) is Correlated with Colorectal Cancer Progression and Poor Prognosis.

Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity

Anillin is a Prognostic Factor and is Correlated with Genovariation in Pancreatic Cancer Based on Databases Analysis

Comprehensive Bioinformatics Analysis Reveals the Prognostic Value, Predictive Value, and Immunological Roles of ANLN in Human Cancers

Clinical implication and immunological landscape analyses of ANLN in pan‐cancer: A new target for cancer research

Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma

Pan-cancer analysis of ANLN expression and prognostic significance

Expression of ANLN in HCC and predictive value for long-term survival of patients after liver transplantation

ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells

Overexpression of ANLN in Lung Adenocarcinoma is Associated with Metastasis.

Transcriptome Sequencing Identifies ANLN As a Promising Prognostic Biomarker in Bladder Urothelial Carcinoma

ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis

LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer

Extracellular matrix expression in non small cell lung cancer and its relationship with neo-adjuvant chemotherapy

Long Noncoding RNA ANRIL As a Novel Biomarker of Lymph Node Metastasis and Prognosis in Human Cancer: a Meta-Analysis

Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer

Study on Prognostic Value of Aromatase in Lymph Node Negative Breast Cancer

Prognostic Value of Lncrna AFAP1-AS1 in Breast Cancer: a Meta-Analysis and Validated Study in Chinese Population

Annexin-1 Downregulation is Associated with Clinical Outcome in Chinese Patients with Hilar Cholangiocarcinoma

ANCCA Protein Expression is a Novel Independent Poor Prognostic Marker in Surgically Resected Lung Adenocarcinoma